Adenosine deaminase levels in serum and cerebrospinal fluid of patients with tuberculous meningitis

Journal Title: Medpulse International Journal of Biochemistry - Year 2019, Vol 9, Issue 1

Abstract

Background: Tuberculosis is one of the oldest human diseases with the highest mortality rate among infectious diseases and is caused by bacteria Mycobacterium tuberculosis complex and usually affects the lungs, although other organs are involved in up to one-third of cases. Adenosine deaminase (ADA) is now being recognized as a marker of cell mediated immunity particularly as a marker of T lymphocyte activation. Adenosine deaminase levels (ADA) have also been considered by several researchers to differentiate tubercular disease from non-tubercular. Purpose: 1) To evaluate the usefulness of enzyme Adenosine deaminase in diagnosis of Tuberculous Meningitis. Methodology: A case control study was conducted and a total of 100 patients were included in the study in which 50 suspected and diagnosed cases of tubercular meningitis patients and 50 healthy subjects taken as controls. Estimation of ADA in both serum and CSF was done by GUISTI AND GALANTI METHOD Results: In the present study, the Mean±SD of serum ADA in TBM cases was 37.54±10.81 and in controls was 11.56±3.240. This implied that tuberculous 56 meningitis patients had high levels of serum ADA levels than controls and the P value was <0.0001. Simultaneous estimation of serum and CSF-ADA have an added advantage to diagnose TB meningitis and differentiate between TBM and pyogenic meiningitis. Conclusions: To conclude, ADA is an enzyme that increases in TB because of the stimulation of T- cell lymphocytes by microbial antigens, SERUM and CSF ADA can be used for early diagnostic marker of Tubercular Meningitis.

Authors and Affiliations

Zeenath Begum . , P V Satya Narayana

Keywords

Related Articles

Correlation of serum malondialdehyde level with components of metabolic syndrome

Background: Metabolic syndrome is one of the major public health concerns and is emerging as a pandemic. oxidative stress is a hallmark of metabolic syndrome and plays a central role in the progression of the disease. Ma...

A study of plasma of HDL level in diabetes mellitus

Background: Numerous studies have shown that HDL cholesterol is strongly and inversely associated with the occurrence of cardiovascular events Aims and Objectives: To Study Plasma of HDL level in Diabetes mellitus. Metho...

Evaluation of thyroid function in patients of chronic kidney disease

Background: Chronic Kidney Disease (CKD) is abnormal kidney function with low GFR (<60 ml/min/1.73m2) for 3 or more months. Prevalence of CKD in India is 17.2% and over 2 million people world wide receive dialysis treatm...

Study of serum GGT and ALT levels as markers of oxidative stress in type 2 diabetes mellitus

Context: The role of oxidant stress in the causation of Diabetes mellitus is increasingly being recognized. Very recently it has also been shown that hypoglutathionaemia and increased oxidative stress appear to be early...

Serum lipid profile and Psoriasis – A case control study

Background: Psoriasis is a chronic inflammatory skin disease characterized by excessive cellular replication. It is associated with an atherogenic lipid profile. The prevalence of cardiovascular disorders in these patien...

Download PDF file
  • EP ID EP521658
  • DOI 10.26611/1002914
  • Views 160
  • Downloads 0

How To Cite

Zeenath Begum . , P V Satya Narayana (2019). Adenosine deaminase levels in serum and cerebrospinal fluid of patients with tuberculous meningitis. Medpulse International Journal of Biochemistry, 9(1), 13-17. https://europub.co.uk/articles/-A-521658